Updated May. 18, 2017 at 6:25 a.m.

Premium Lock RTP's G1 Therapeutics goes public with $105M IPO

Published: 2017-05-17 11:17:00
Updated: 2017-05-18 06:25:01

G1 Therapeutics  G1 Therapeutics Image 1 of 2 · Next Image…

G1 Therapeutics, a clinical-stage oncology company based in Research Triangle Park, became a publicly traded entity today with a $105 million initial public offering of seven million shares of stock priced at $15 a share....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders